CGBIO_CN
CGBIO
Menu
  • 公司介绍
    • 介绍
    • CE0问候语
    • 业务领域
    • 国际事业部
    • 公司发展历程
  • 研究开发
    • 研究所介绍
    • 研究领域
    • 证书及专利
    • 论文
  • 产品信息
    • 论文
    • Wound
    • Aesthetics
    • Dental
  • CN
    • KOR
    • ENG
    • JP
    • TH
    • ID
    • ES
Open
Close
Sitemap
시지바이오 사이트맵 닫기
公司介绍
介绍
CE0问候语
业务领域
国际事业部
公司发展历程
研究开发
研究所介绍
研究领域
证书及专利
论文
产品信息
All
Wound
  • CURAVAC
  • CuraVAC SILVER
  • Curasys
  • EASYFOAM
  • EASYFOAM SILICONE BORDER
  • EASYDERM PLUS THIN
AESTHETICS
  • GISELLELIGNE
  • Cellunit
Dental
  • Bongros
home

研究开发

Wound

  • 研究所介绍
  • 研究领域
  • 证书及专利
  • 论文
Research Info
Early recombinant human epidermal growth factor treatment recovers the irradiation-induced decrease of Na+ absorption prior to the definite histological mucositis
  • 2015-03-19
  • cgbio
  • 조회수Views : 704 views

Kim JK, Kim CS, Ahn HJ, et al.

Early recombinant human epidermal growth factor treatment recovers the irradiation-induced decrease of Na+ absorption prior to the definite histological mucositis.

Biomed Pharmacother 2010; 64(9): 594-9.

NEXT
Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis
PREV
Epidermal growth factor induces cell death in the absence of overexpressed epidermal growth factor receptor and ErbB2 in various human cancer cell lines.
LIST

Head Office : F3, 211, Itaewon-ro, Yongsan-gu, Seoul, Korea
Research Institute : 244, Galmachi-ro,Jungwon-gu,Seongnam-si, Gyeonggi-do,Korea
Head Office TEL. +82-2-550-8300

Copyright All Right Reserverd By CGbio

인스타그램 페이스북

  • Family site
    • DaewoongPhamercy
    • Daewoong Bio
    • DNC
    • Bio-Alpha

to be updated.

OK close